Germany
subrosa health partners with start-up-, rare disease- and other biotech companies providing strategic go-to-market-consulting, recruitment and end-to-end medical & commercial (launch) services focussed on therapies for genetic and non-genetic based diseases - unchaining business opportunities, identifying new patient populations and de-risking your investments - globally. #globalrarediseases #marketaccess consulting #patientidentification #clinicalresearch #PSPs #medicalservices #commercialservices #launchexecution #omnichannel #executivesearch #recruitment #globalpartnering #biopharmaonly #investM&A
Investor in Healthcare
C-Level-Consultancy US & EMEA
For over a decade after its foundation, pharmexx, a pharmaceutical contract sales organisation, was one of the fastest growing and most awarded companies in Europe. At a level of 260 m€ p.a. service revenue and more than 5.000 employees in 63 entities (in Germany, Austria, France, Spain, Portugal, Italy, Belgium, Netherlands, UK&Ireland, Sweden, Finnland, Denmark, Norway, Turkey, Czech Republic, Canada, India, Brazil, Argentina, Chile) first Celesio, then Ashfield/Inizio acquired and integrated pharmexx.